Abstract:There is large interest in the early diagnosis of Alzheimer's disease (AD) using machine learning. The NIH-sponsored Alzheimer's Disease Connectome Project (ADCP), a multi-center MRI, PET, and behavioral study of brain connectivity in AD, has a specific aim of accurately staging AD throughout its progression on an individual basis. It uses state-of-the-art MRI imaging techniques which allow for building reliable machine learning models. In this ongoing project, we are training models with the MRI structural brain features to separate between healthy controls and a group of AD and mild cognitive impairment (MCI) patients. Data from 12 patients (age=70.8±6.6 years, 7 males, 4 AD patients), and 20 healthy controls (age=68.9±6.2 years, 11 males), enrolled in ADCP, were analyzed. The two groups matched in age (p=0.45) and gender ratio (p=0.85). All images were acquired with 3T GE 750 scanners. T1-weighted images were acquired using a magnetization prepared gradient echo sequence (TR/TE=604ms/2.516ms, 0.8mm isotropic). Data were pre-processed using FreeSurfer-based Human Connectome Project (HCP) processing pipelines. 269 structural features were extracted, which include cortical thicknesses, surface areas, and subcortical and global volumes. They were normalized with the individual intracranial volume and then with the standardized z-score transform. 3 traditional binary classification machine learning models were trained in Matlab: support vector machine (SVM), linear discriminant analysis (LDA), and naïve Bayes (NB) classifiers. We applied a t-test based filter selection method, where only a group of features with the largest group mean differences in the training set enters the training. For performance estimation, we used leave-one-out cross validation (LOOCV) and the area-under-the-curve (AUC). SVM model classified the two groups with 90.6% accuracy (sensitivity=83.3%, specificity=95.0%, AUC=0.78, 23 features). NB model reached 84.38% (sensitivity=83.3%, specificity=85.0%, AUC=0.83, 10 features). Bilateral temporal pole volumes and right entorhinal volume were the most discriminating features. Linear traditional machine learning models were able to separate between AD/MCI patients and healthy controls with mid-80 to 90% accuracy. This is promising as it is known that non-linear, deep learning methods will outperform these traditional models given more data in the future. Building an automated model to classify Alzheimer's patients is expected to aid early diagnosis . A t-test based filter selection method was used to let only a certain number of features with the most group difference to be used in the training. SVM reached the highest LOOCV accuracy at 90.6% using 23 features. Bilateral temporal pole volumes showed the most group differences and helped machine learning separate the two groups. The volumes are noticeably reduced in MCI and AD patients compared to the healthy controls.

Alzheimer Disease Detection from Raman Spectroscopy of the Cerebrospinal Fluid via Topological Machine Learning

Harnessing topological machine learning in Raman spectroscopy: Perspectives for Alzheimer's disease detection via cerebrospinal fluid analysis

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics

Early Detection of Alzheimer’s Disease Using Non-invasive Near-Infrared Spectroscopy

Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics

Machine Learning-Assisted Classification of Paraffin-Embedded Brain Tumors with Raman Spectroscopy

Ultrasensitive Detection of Blood-Based Alzheimer's Disease Biomarkers: A Comprehensive SERS-Immunoassay Platform Enhanced by Machine Learning

Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer's disease with MRI and CSF biomarkers

Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?

CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING

Raman signature from brain hippocampus could aid Alzheimer's disease diagnosis.

Multi-branch attention Raman network and surface-enhanced Raman spectroscopy for the classification of neurological disorders

Raman spectroscopy and topological machine learning for cancer grading

Raman Spectroscopy Detection of Platelet for Alzheimer’s Disease with Predictive Probabilities

Research on Voxel-Based Features Detection and Analysis of Alzheimer's Disease Using Random Survey Support Vector Machine

An integrated computational pipeline for machine learning-driven diagnosis based on Raman spectra of saliva samples

Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA

Machine Learning Classification of Alzheimer's Disease Stages Using Cerebrospinal Fluid Biomarkers Alone

Biomarker Investigation using Multiple Brain Measures from MRI through XAI in Alzheimer's Disease Classification

Chemiluminescence signature arrays coupling with machine learning for Alzheimer’s disease serum diagnosis